American Century Companies’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.6M Buy
574,474
+382,898
+200% +$30.7M 0.02% 878
2026
Q1
$14.7M Buy
191,576
+133,330
+229% +$10.4M 0.01% 1306
2025
Q4
$4.6M Buy
58,246
+26,986
+86% +$2.34M ﹤0.01% 1758
2025
Q3
$2.86M Buy
31,260
+11,807
+61% +$963K ﹤0.01% 1941
2025
Q2
$1.27M Sell
19,453
-6,384
-25% -$416K ﹤0.01% 2189
2025
Q1
$1.73M Sell
25,837
-34,411
-57% -$2.06M ﹤0.01% 2048
2024
Q4
$3.33M Sell
60,248
-27,239
-31% -$1.56M ﹤0.01% 1780
2024
Q3
$5.22M Sell
87,487
-12,344
-12% -$753K ﹤0.01% 1560
2024
Q2
$6.36M Buy
99,831
+49,717
+99% +$3.23M ﹤0.01% 1426
2024
Q1
$3.46M Buy
50,114
+34,493
+221% +$2.08M ﹤0.01% 1628
2023
Q4
$861K Buy
15,621
+3,706
+31% +$204K ﹤0.01% 2135
2023
Q3
$692K Buy
11,915
+3,880
+48% +$224K ﹤0.01% 2139
2023
Q2
$433K Buy
+8,035
New +$356K ﹤0.01% 2280
2020
Q2
Sell
-7,390
Closed -$301K 1721
2020
Q1
$301K Buy
+7,390
New +$393K ﹤0.01% 1309
2018
Q4
Sell
-36,845
Closed -$2.08M 1234
2018
Q3
$2.08M Buy
36,845
+417
+1% +$25.5K ﹤0.01% 1021
2018
Q2
$2.43M Buy
+36,428
New +$2.27M ﹤0.01% 987

Other funds holding ANIP

American Century Companies's ANIP Position: Q2 2026 in Review

American Century Companies increased its ANI Pharmaceuticals (ANIP) stake by 200% in Q2 2026, buying an estimated $30.7M and bringing the position to 574,474 shares worth $47.6M. The position accounts for 0.02% of the portfolio, ranked #878.

American Century Companies first reported a position in ANIP in Q2 2018 and has held it in 16 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • American Century Companies held 574,474 shares of ANI Pharmaceuticals worth $47.6M as of Q2 2026.
  • American Century Companies bought 382,898 ANI Pharmaceuticals shares in Q2 2026, an estimated $30.7M.
  • ANI Pharmaceuticals made up 0.02% of American Century Companies's portfolio in Q2 2026, its #878 holding.
  • American Century Companies first reported a position in ANI Pharmaceuticals in Q2 2018 and has held it in 16 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.